Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 15,896 | 7,558 | 5,465 | 2,515 | 2,802 |
| Gross Profit | 15,896 | 7,558 | 5,465 | 2,515 | 2,802 |
| Operating Expenses | 49,295 | 39,045 | 34,172 | 37,007 | 31,880 |
| Operating Income | -33,399 | -31,487 | -28,707 | -34,492 | -29,078 |
| Interest Expense | 0 | 0 | 0 | 0 | 538 |
| Other Income | -19,712 | -27,197 | 635 | 972 | 1,314 |
| Pre-tax Income | -53,111 | -58,684 | -28,072 | -33,520 | -28,302 |
| Net Income Continuous | -53,111 | -58,684 | -28,072 | -33,520 | -28,302 |
| Net Income | $-53,111 | $-58,684 | $-28,072 | $-33,520 | $-28,302 |
| EPS Basic Total Ops | -0.63 | -0.68 | -0.35 | -0.44 | -0.38 |
| EPS Basic Continuous Ops | -0.63 | -0.68 | -0.35 | -0.44 | -0.38 |
| EPS Diluted Total Ops | -0.63 | -0.68 | -0.35 | -0.44 | -0.38 |
| EPS Diluted Continuous Ops | -0.63 | -0.68 | -0.35 | -0.44 | -0.38 |
| EBITDA(a) | $-29,833 | $-29,795 | $-27,236 | $-33,348 | $-28,120 |